thyroid cancer

FDA Approves Selpercatinib for Pediatric Patients With RET-Altered Metastatic Thyroid Cancer, Solid Tumors
Oncology Nursing News
Wed, 05/29/24 - 09:41 pm
Eli Lilly
FDA
Retevmo
pediatrics
thyroid cancer
GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study
BioSpace
Wed, 04/10/24 - 09:48 am
Novo Nordisk
Ozempic
Victoza
GLP-1 agonist
thyroid cancer
Eli Lilly axes next-generation, resistance-busting RET inhibitor
Fierce Biotech
Tue, 02/6/24 - 10:14 am
Eli Lilly
LOXO-260
RET inhibitors
thyroid cancer
non-small cell lung cancer
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Wed, 08/23/23 - 10:12 am
Eli Lilly
Retevmo
thyroid cancer
medullary thyroid cancer
clinical trials
Exelixis
Capometyx
Sanofi
Caprelsa
Novo Nordisk says EMA raised safety signal on drugs including semaglutide
Yahoo/Reuters
Thu, 06/22/23 - 10:21 am
Novo Nordisk
EMA
semaglutide
Ozempic
Wegovy
thyroid cancer
obesity
diabetes
Exelixis pulls a surprise win in thyroid cancer just days ahead of final Cabometyx readout
Endpoints
Mon, 09/20/21 - 11:57 am
ESMO
Exelixis
thyroid cancer
Cabometyx
ASCO: Exelixis releases more details on Cabometyx thyroid cancer data that wooed Ipsen
Fierce Pharma
Thu, 05/20/21 - 12:15 pm
ASCO 2021
Ipsen
Exelixis
Cabometyx
thyroid cancer
clinical trials
Exelixis' Cabometyx scores backing from Ipsen in thyroid cancer, with full data release set for ASCO
Fierce Pharma
Wed, 05/12/21 - 11:39 pm
Exelixis
Cabometyx
Ipsen
thyroid cancer
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Pharmaforum
Wed, 12/2/20 - 10:33 am
Roche
Blueprint Medicines
Gavreto
thyroid cancer
Retevmo
Eli Lilly
Racing Blueprint, Lilly drug gets priority review for RET hopeful
Fierce Biotech
Wed, 01/29/20 - 10:35 am
Eli Lilly
FDA
Blueprint Medicines
selpercatinib
LOXO-292
thyroid cancer
non-small cell lung cancer
AI Mines Clinical Data for Thyroid Cancer Therapeutic Targets
Medical Devices and Diagnostics Industry
Tue, 08/13/19 - 10:24 am
thyroid cancer
artificial intelligence
diagnostics
Predictive Oncology
Interpace Diagnostics
Exelixis Hits Blockbuster Status
Motley Fool
Mon, 08/5/19 - 10:45 am
Exelixis
cabozantinib
Cabometx
kidney cancer
liver cancer
Cometriq
thyroid cancer
Veracyte Presents Data Demonstrating Afirma's Success in Reducing Unnecessary Surgery
CP Wire
Mon, 10/8/18 - 10:55 pm
Veracyte
diagnostics
thyroid cancer
thyroid nodules
Veracyte Presents Data Demonstrating Afirma's Success in Reducing Unnecessary Surgery
Mon, 10/8/18 - 10:08 am
Veracyte
thyroid cancer
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
CP Wire
Mon, 10/8/18 - 09:55 am
Exelixis
Cabometyx
thyroid cancer
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
Mon, 10/8/18 - 09:25 am
Exelixis
Cabometyx
thyroid cancer
Could a New Imaging Device Curb Thyroid Cancer?
Medical Devices and Diagnostics Industry
Wed, 08/8/18 - 10:39 pm
AmCad BioMed
thyroid cancer
diagnostics
Eisai's Lenvima posts big growth numbers as Merck collaboration rolls into action
Fierce Pharma
Fri, 08/3/18 - 11:33 am
Merck
Eisai
Lenvima
kidney cancer
thyroid cancer
AstraZeneca’s selumetinib flops in thyroid cancer, adding to list of failures
Fierce Biotech
Fri, 07/27/18 - 10:00 am
AstraZeneca
thyroid cancer
selumetinib
Eisai's launch for 'crown jewel' Lenvima tracking better than execs expected
Fierce Pharma Marketing
Tue, 07/28/15 - 12:00 pm
Eisai
Lenvima
thyroid cancer

Pages